Pharma 10 2016 ranking

2016
2015
Name
Country
2016
2015
2016
2015
1 4 Pfizer United States $4,401M $3,281M AA+ AA+
2 1 Bayer Germany $4,365M $4,746M AAA- AAA-
3 3 Novartis Switzerland $4,096M $3,817M AA AAA-
4 2 Roche Switzerland $3,892M $4,251M AA+ AAA-
5 5 Merck & Co United States $2,901M $3,136M AA AAA-
6 7 Glaxosmithkline United Kingdom $2,781M $2,890M AA AA+
7 6 Sanofi France $2,704M $3,062M AA- AA+
8 10 Celgene United States $2,642M $2,043M AA- AA-
9 9 Valeant Pharmace Canada $2,469M $2,131M A+ AA-
10 8 Biogen United States $2,345M $2,769M AA AA+
Loading...